In recent trading session, Tenaya Therapeutics Inc (NASDAQ:TNYA) saw 0.87 million shares changing hands at last check today with its beta currently measuring 2.99. Company’s recent per share price level of $0.51 trading at -$0.06 or -10.44% at last check today assigns it a market valuation of $82.40M. That most recent trading price of TNYA’s stock is at a discount of -900.0% from its 52-week high price of $5.10 and is indicating a premium of 23.53% from its 52-week low price of $0.39. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.76 million shares which gives us an average trading volume of 3.36 million if we extend that period to 3-months.

For Tenaya Therapeutics Inc (TNYA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.2 in the current quarter.

Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information

Upright in the red during last session for losing -10.44%, in the last five days TNYA remained trading in the red while hitting it’s week-highest on Friday, 03/28/25 when the stock touched $0.51 price level, adding 26.09% to its value on the day. Tenaya Therapeutics Inc’s shares saw a change of -64.56% in year-to-date performance and have moved -26.74% in past 5-day. Tenaya Therapeutics Inc (NASDAQ:TNYA) showed a performance of 11.38% in past 30-days. Number of shares sold short was 11.22 million shares which calculate 1.96 days to cover the short interests.

Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders

Insiders are in possession of 1.42% of company’s total shares while institution are holding 106.79 percent of that, with stock having share float percentage of 108.33%. Investors also watch the number of corporate investors in a company very closely, which is 106.79% institutions for Tenaya Therapeutics Inc that are currently holding shares of the company. COLUMN GROUP LLC is the top institutional holder at TNYA for having 9.4 million shares of worth $29.14 million. And as of 2024-06-30, it was holding 10.968 of the company’s outstanding shares.

The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 7.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.8935 of outstanding shares, having a total worth of $23.63 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 2.06 shares of worth $1.04 million or 2.36% of the total outstanding shares. The later fund manager was in possession of 1.42 shares on Feb 28, 2025, making its stake of worth around $0.72 million in the company or a holder of 1.63% of company’s stock.